Scilex Holding (NASDAQ:SCLXW – Get Free Report) shares shot up 5.2% during mid-day trading on Tuesday . The company traded as high as $0.2098 and last traded at $0.2098. 12,952 shares were traded during trading, a decline of 39% from the average session volume of 21,088 shares. The stock had previously closed at $0.1994.
Scilex Price Performance
The firm’s fifty day simple moving average is $0.21 and its 200-day simple moving average is $0.25.
About Scilex
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
See Also
- Five stocks we like better than Scilex
- What Are Dividend Contenders? Investing in Dividend Contenders
- Warner Bros. Sale Rumors Heat Up: What Investors Need to Know
- 3 Dividend Kings To Consider
- From Science Project to Solvent: WeRide’s 761% Revenue Surge
- How to start investing in penny stocks
- Will the S&P 500 Rally in December? These 3 Signals Point to a Big Move Ahead
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
